YAP1 and hepatoblastoma: Silencing of YAP led to decrease in the SLC38A1 expression and inhibition of mTORC1 suggesting that the activation of YAP-β catenin may induce activation of mTORC1 to promote the development of hepatoblastoma by inducing the expression of SLC38A1 [40].